priorix albumin free vaccine 0.5ml powder for injection vial
glaxosmithkline australia pty ltd - mumps virus, quantity: 5000 ccid50; measles virus, quantity: 1000 ccid50; rubella virus, quantity: 1000 ccid50 - injection, powder for - excipient ingredients: lactose; sorbitol; mannitol; threonine; serine; proline; glycine; alanine; valine; methionine; isoleucine; leucine; tyrosine; tryptophan; lysine hydrochloride; histidine; arginine; phenylalanine - priorix is indicated for active immunisation against measles, mumps and rubella from 12 months of age.
virus nosode 4003- virus nosode liquid
professional complementary health formulas - all the following at 30x, 60x, 100x: bcg coxsackievirus cytomegalovirus epstein-barr virus haemophilus influenzae poliomyelitis roseola rubella vaccinotoxinum varicella - temporarily relieves fatigue, sore throat, minor aches and pains in the muscles or joints, occasional headache, chills, sweats, cough, nausea or vomiting, or abdominal discomfort.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.
eolarix vaccine
glaxosmithkline consumer healthcare (ireland) limited - measles virus - schwarz strain live attenuated rubella virus (ra 27/3 strain) - solution for injection - 0.5 millilitre
eolarix vaccine
glaxosmithkline consumer healthcare (ireland) limited - measles virus - schwarz strain live attenuated rubella virus (ra 27/3 strain) - solution for injection
priorix-tetra
glaxosmithkline australia pty ltd - measles virus; rubella virus; mumps virus; varicella vaccine - live -
boostrix polio – suspension for injection. diphtheria, tetanus, pertussis (acellular component) and poliomyelitis (inactivated) vaccine (adsorbed)
glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - pertactin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, filamentous haemagglutinin, fha, tetanus toxoid - suspension for injection - diphtheria toxoid filamentous haemagglutinin (fha) 8 µg pertactin 2.5 µg pertussis toxoid 8 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu poliovirus (inactivated) type 3 (saukett strain) 32 dagu tetanus toxoid - vaccines
ipv-boostrix suspension for injection in pre-filled syringe
glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - pertactin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, filamentous haemagglutinin, fha, tetanus toxoid - suspension for injection in pre-filled syringe - pertactin 2.5 µg pertussis toxoid 8 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu poliovirus (inactivated) type 3 (saukett strain) 32 dagu diphtheria toxoid filamentous haemagglutinin (fha) 8 µg tetanus toxoid - vaccines
priorix vaccine (mmr)
glaxosmithkline pharmaceutical sdn. bhd. - live attenuated measles virus; live attenuated rubella virus; live attenuated mumps virus -
priorix, powder and solvent for solution for injection in a pre-filled syringe
nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - measles virus, schwarz strain, ccid, mumps vaccine, rit, rubella virus, wistar ra - powder and solvent for solution for injection in pre-filled syringe - measles virus - schwarz strain not less than 10 ccid50 mumps vaccine rit 4385 not less than 10 ccid50 rubella virus - wistar ra27/3 strain not less than 10 ccid50 - vaccines
polio sabin one and three (oral) vaccine
glaxosmithkline pte ltd - virus polio type 1, strain lsc, 2ab; virus polio type 3, strain leon 12a, 1b - suspension - virus polio type 1, strain lsc, 2ab ≥10⁶·˚ccid₅₀; virus polio type 3, strain leon 12a, 1b ≥10⁵·⁸ccid₅₀